Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117263870A details high-yield Resmetirom intermediate III synthesis with reduced cost and environmental impact for global pharmaceutical supply chains.
Novel electrochemical method replaces gold catalysts for trans-olefin production. High purity, room temperature process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Cu-catalyzed method for Tazobactam Sodium synthesis. Delivers safer, scalable, and cost-effective production solutions for global pharmaceutical supply chains and procurement teams.
Patent CN105906649B details asymmetric synthesis of chiral spirolides. Offers high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN107721984A enables high-yield triazole synthesis. Offers cost reduction in pharma manufacturing and reliable supply chain for API intermediates.
Novel synthetic route for 8-azacoumarins offering high yield and solubility for pharma supply chains. Scalable process from patent CN106810560A.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN117603100B reveals a green one-pot synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN111138492B details a high-yield Brigatinib synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for API manufacturing.
Patent CN104817484A reveals metal-free 2-indolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Patent CN108586211B reveals a cost-effective Pd-catalyzed decarboxylative coupling method for 1,1-diarylethene derivatives, offering significant supply chain advantages.
Patent CN101302191B details a high-yield Vilsmeier cyclization for 3-formyl-4-halopyridin-2-ones, offering cost-effective manufacturing and reliable supply chain solutions.
Novel asenapine preparation method using Red-Al ensures safety and scalability. Ideal for pharmaceutical intermediate supply chains seeking cost-effective solutions globally.
Patent CN110950739A reveals a mild, room-temperature photocatalytic method for ortho-fluorination. Ideal for high-purity pharmaceutical and agrochemical intermediates with reduced costs.
Patent CN103113290A details a cost-effective Pd/C catalyzed route for 3-methylaminopiperidine, offering significant supply chain advantages for fluoroquinolone producers.
Advanced Pd-Cu catalytic method for phenanthrene intermediates. Enhances yield and supply chain stability for pharmaceutical manufacturing partners globally.
Novel solvent system reduces toxic Impurity H in Ceftazidime synthesis, ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN108640945B reveals a novel Ru/Ir-catalyzed direct C-H alkynylation of amides. This method eliminates directing groups, offering cost-effective routes for high-purity pharmaceutical intermediates.
Novel hydroxylamine hydrochloride route for Lafutidine improves purity to 99.88% and reduces impurities significantly for reliable pharmaceutical intermediates supply chain stability.